Isis Cruz

[Isis Cruz @Isiscruzv]

@MMescyt @EducacionRDo @PresidenciaRD @raquelarbaje

[Isis Cruz @Isiscruzv]

¡Holaaa! Hace un mes he intentado ponerme en contacto con el @MMescyt y no obtengo respuesta.

Hace un mes me aceptaron en la Universidad de Oxford y la Universidad de Cambridge para cursar estudios de máster en investigación.

[Isis Cruz @Isiscruzv]

Oxford tiene una fecha límite para cumplir con las condiciones de la oferta, por lo que tengo poco tiempo para aceptar o declinar. Si tienen cualquier sugerencia o simplemente pueden hacer eco de esta publicación, se los agradecería muchísimo.

[Isis Cruz @Isiscruzv]

Un buen momento para recodar esta joyita.

[Isis Cruz @Isiscruzv]

HAHAHAHAHA, love it 🤣🤣 that’s the mood!!

[Isis Cruz @Isiscruzv]

Nature conoce su público 🤣🤣

[Happy Researchers @hapyresearchers]

I had no exp. in scientific paper writing whn I started PhD. Even after publishing∼40papers, the 1st drft of mypapers looks unsatisfactory in the 2nd reading.

If you're struggling to write ur 1st paper so ask for help as skills to write a good paper comes with time & practice.

[Neil Renic @NC_Renic]

Academic success is 2% intelligence, 98% typing two sentences without getting distracted

[Isis Cruz @Isiscruzv]

@goodreads No.

[Isis Cruz @Isiscruzv]

Libro recomendado 👏🏻👏🏻

[🎙️Laureano de la Cruz, PhD @lauredelacruz]

Si usted entiende el problema de la franja de Gaza como un conflicto entre buenos y malos, usted no ha entendido nada.

#Gaza

[Mushtaq Bilal, PhD @MushtaqBilalPhD]

Nature rejected her paper for not being original,

University of Pennsylvania (her employer) demoted her,

and yesterday Katalin Karikó won the Noble Prize in physiology.

In mid-2000s, Karikó and her Drew Weismann submitted their paper on mRNA (messenger Ribonucleic Acid) to Nature.

Nature desk rejected their paper for being "an incremental contribution" only. The paper was later published in another journal, Immunity.

Earlier in her career at the University of Pennsylvania, Karikó was demoted because her applications for grants kept getting rejected.
But Karikó persevered and kept on going.

In 2013, she joined BioNTech, a German company founded by two scientists, Uğur Şahin and Özlem Türeci. In 2018, BioNTech partnered with Pfizer to develop mRNA vaccines against the influenza virus.

When the COVID-19 hit the world, Karikó's research helped Pfizer to produce the first vaccine against the disease.

I don't know how the Nature editors who desk rejected Karikó's paper and the Penn administration who demoted her feel about Karikó Nobel Prize.

Takeaway: Many academics and scientists worry about getting published in "prestigious" journals. Instead of worrying about prestige, we should try to put our work out as quickly as possible like Karikó did.

Once you put your work out without caring about prestige, two good things happen:

1. Your work will lead to newer opportunities.
2. You will start getting feedback from the scholarly community, which you can use to iterate and improve.

Here's another interesting Nobel Prize story.

Peter Higgs, a British physicist, joined the University of Edinburgh in 1956. By 1964, Higgs has published his groundbreaking work about subatomic particles.

After 1964, Higgs published less than 10 papers.
When his department would ask him how many papers, he published in a given year, he would reply "None."

It happened so often that he stared feeling like an "embarrassment to the department."

The University of Edinburgh, however, never fired Higgs because in 1980 he had been nominated for the Nobel Prize.

Higgs retired in 1996 and stayed on as an emeritus professor at Edinburg.

In 2012, experiments conducted at the CERN laboratory confirmed Higgs work and the existence of Higgs Particle.

And in 2013, Higgs was awarded the Noble Prize in physics and the University of Edinburgh got rewarded for being patient.

[Lebanna @AnnabelHalliday]

The price of mirrors was one of the most shocking adult discoveries

[Isis Cruz @Isiscruzv]

Aciago día en el que hundieron la Grande y Felicísima Armada. 😂

[cinesthetic. @TheCinesthetic]

What's the best moment where a character REALIZES something?

[Isis Cruz @Isiscruzv]

…cese por fin. Ese día reinaré verdaderamente en el silencio definitivo de la servidumbre. (Ríe.) Es un problema de obstinación, ¿verdad? Pero estad tranquilos; yo tengo la frente baja de los testarudos.

Me encantó esta obra. 👏🏻 Mi personaje favorito fue NADA

[Isis Cruz @Isiscruzv]

LA PESTE. La crueldad rebela, pero la tontería descorazona. ¡Honor a los estúpidos, porque ellos preparan mis caminos! ¡Son mi fuerza y mi esperanza! Llegará un día, acaso, en que todo sacrificio os parecerá estéril, en que el grito interminable de vuestras sucias rebeliones…